The Protocol of Choice for Treatment of Snake Bite

Table 2

Follow-up data on three common snakebite protocols ().

Variable	WHO	GF	Haddad	Sig.	Posttest
Antivenom used vials; (min, max)	5 2, 6; (2, 18)	5 5, 8; (0, 30)	10 10, 12; (10, 12)	.016	, Haddad-WHO; , GF-Haddad
Deformity; (%)	2 (10.5)	5 (17.9)	0	NS	—
Amputation; (%)	1 (5.3)	1 (3.6)	0	NS	—
Fasciotomy; (%)	0	4 (14.3)	0	NS	—
Necrosis; (%)	1 (5.3)	0	1 ()	NS	—
Neuropathy; (%)	0	1 (3.6)	0	NS	—
Serum sickness; (%)	7 (36.8)	2 (7.1)	1 ()	.04	, GF-WHO
Hospital stay (day); (min, max)	2 1, 2; (1, 12)	3 2, 4; (1, 9)	3 [1.5, 4.5]; (1, 5)	.035	, WHO-GF

Using post hoc adjusted test. Using Pearson chi-square.